TABLE 1.
Characteristics of the study population (N = 3254)
| Age, years (SD) | 62.1 | (11.5) |
| Sex, female (%) | ||
| ≤60 years old | 1054 | (77.3) |
| >60 years old | 738 | (39.0) |
| Diagnosis, (%) | ||
| Breast cancer | 886 | (27.2) |
| Haematological cancer | 579 | (17.8) |
| Colon cancer | 563 | (17.3) |
| Prostate cancer | 400 | (12.3) |
| Bladder cancer | 195 | (6.0) |
| Melanoma/skin cancer | 120 | (3.7) |
| Gynaecological cancer | 118 | (3.6) |
| Lung cancer | 77 | (2.4) |
| Other | 316 | (9.7) |
| Median time since last treatment (IQR) | 2 | (0–5) |
| Median time since last treatment decision (IQR) | 2 | (0–5) |
| Hospital type where patients were treated (%) | ||
| Academic (or specialised in cancer‐care) | 1013 | (31.1) |
| “Top‐clinical” | 1277 | (39.2) |
| General | 917 | (28.2) |
| Other | 47 | (1.4) |
| Median number of HCPs involved (IQR) | 1 | (1–2) |
Abbreviations: HCPs, health care providers; IQR, interquartile range; SD, standard deviation.